Compare Baxter International Inc (BAX) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baxter International Inc vs Illumina, Inc. — how do they compare? Baxter International Inc trades at $27.61 (market cap $14.27B), while Illumina, Inc. trades at $193.06 (market cap $29.12B). The key difference: Illumina, Inc. is far larger — about 2× Baxter International Inc's market cap, and Baxter International Inc pays a 0.14% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| BAX | ILMN | |
|---|---|---|
Market Cap | $14.27B | $29.12B |
Sector | Health | Health |
52-Week High | $28.35 | $205.10 |
52-Week Low | $15.80 | $91.00 |
Enterprise Value | $21.79B | $30.48B |
Dividend Yield | 0.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
